Endocrine is led by John Hart, the company’s CEO. Dr Hart has a PhD in biochemistry (endocrine pathology) and has worked as a business development specialist with many science and technology companies, including Amersham (now part of GE Healthcare) and AEA Technology.
The Scientific Advisory Board is chaired by Russ Newton, Emeritus Professor of Biochemistry in Swansea University.
For more information on Endocrine Pharmaceuticals, please use the following contact details:
Endocrine Pharmaceuticals Limited
Tadley Common Road
Telephone: +44 (0) 7866 364562
Copyright @ 2018 Endocrine Pharmaceuticals Ltd.. All Rights Reserved
Site designed and maintained by Ben Philip - email@example.com